Sanofi (Exubera) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Sanofi (Exubera) General Information
Description
Worldwide rights of Exubera, an inhaled, dry powder form of human insulin. Exubera is a rapid-acting, dry powder human insulin that is inhaled through the mouth into the lungs prior to eating, using a portable, handheld inhaler.
Contact Information
Corporate Office
- Frankfurt
- Germany
Corporate Office
- Frankfurt
- Germany
Sanofi (Exubera) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sanofi (Exubera) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Sanofi (Exubera) FAQs
-
Where is Sanofi (Exubera) headquartered?
Sanofi (Exubera) is headquartered in Frankfurt, Germany.
-
What industry is Sanofi (Exubera) in?
Sanofi (Exubera)’s primary industry is Buildings and Property.
-
Is Sanofi (Exubera) a private or public company?
Sanofi (Exubera) is a Private company.
-
What is the current valuation of Sanofi (Exubera)?
The current valuation of Sanofi (Exubera) is 00.00.
-
What is Sanofi (Exubera)’s current revenue?
The current revenue for Sanofi (Exubera) is 000000.
-
Who are Sanofi (Exubera)’s investors?
Sanofi has invested in Sanofi (Exubera).
-
When was Sanofi (Exubera) acquired?
Sanofi (Exubera) was acquired on 28-Feb-2006.
-
Who acquired Sanofi (Exubera)?
Sanofi (Exubera) was acquired by Pfizer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »